Prescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- What would a U.S.-Russia war look like?
- Scottish independence is another financial crisis waiting to happen
- Fall movie guide: All the films you should see in September
- Hey, grammar nerds! Stop freaking out about 'alot.'
- 10 things you need to know today: September 1, 2014
- Why the West should let Russia have eastern Ukraine
- The elusive 'It factor' in presidential politics
- 7 things the world's happiest people do every day
- The 10 best networking tips for people who hate networking
- 11 scientific studies that will restore your faith in humanity
Subscribe to the Week